Nosocomial fungemia by Candida auris: first four reported cases in continental Europe

Ruiz Gaitán, Alba Cecilia; Moret, Ana; López Hontangas, José Luis; Molina, José Miguel; Aleixandre López, Ana Isabel; Hernández Cabezas, Alicia; Mollar Maseres, Juan; Chouman Arcas, Rabat; Gómez Ruiz, María Dolores; Chiveli, Miguel Ángel; Cantón, Emilia; Pemán, Javier.
Rev. iberoam. micol ; 34(1): 23-27, ene.-mar. 2017. tab
Artículo en Inglés | IBECS (España) | ID: ibc-160730

Documentos relacionados

  1. Comparison of fungemia caused by Candida and non-Candida rare yeasts: a retrospective study from a tertiary care hospital.
  2. Candida haemulonii complex, an emerging threat from tropical regions?
  3. Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
  4. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
  5. Increase in Candida parapsilosis fungemia in critical care units: a 6-years study.
  6. Distribution of fungemia agents in five years and antifungal resistance.
  7. Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
  8. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
  9. Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity.
  10. Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy.